
Sign up to save your podcasts
Or


Obstacles with platinum rechallenge could lead to treatment burden, but a second-line alternative therapy could be a better option for some of our patients. To learn more, Dr. Charles Turck is joined by Drs. Jacob Sands and Joshua Sabari to share their insights on this therapy for patients with small cell lung cancer.
By ReachMD4.5
22 ratings
Obstacles with platinum rechallenge could lead to treatment burden, but a second-line alternative therapy could be a better option for some of our patients. To learn more, Dr. Charles Turck is joined by Drs. Jacob Sands and Joshua Sabari to share their insights on this therapy for patients with small cell lung cancer.